Theriva Biologics
TOVX
TOVX
28 hedge funds and large institutions have $1.93M invested in Theriva Biologics in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 23 reducing their positions, and 28 closing their positions.
Holders
28
Holders Change
-23
Holders Change %
-45.1%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
23
Closed
28
Calls
$13.6M
Puts
–
Net Calls
+$13.6M
Net Calls Change
+$12.4M
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$118K |
| 2 |
VF
2
Virtu Financial
New York
|
$88K |
| 3 |
3
Jane Street
New York
|
$49K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $0 | 29 | -971 | -97% |
|
52
SEI Investments
Oaks,
Pennsylvania
| – | – | -715 | Closed |
|
|
FHA
53
Flagship Harbor Advisors
Boston,
Massachusetts
| $0 | 15 | -485 | -97% |
|
54
Wells Fargo
San Francisco,
California
| $0 | 1 | -32 | -97% |
|
|
CFGS
55
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
56
Alyeska Investment Group
Chicago,
Illinois
| – | – | – | – |
|
|
KF
57
Krilogy Financial
St. Louis,
Missouri
| $0 | 29 | +29 | New |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| $0 | 100 | +100 | New |
|